Other

Varian Medical Systems, Inc.

Varian Medical Systems Technologies, Inc.

Raisa Pavlyuchkova

Larry D Partain

George Zentai

Stavros Prionas

Edward J Seppi

James Edward Clayton

Majid L Riaziat

Arundhuti Ganguly

Mingshan Sun

Kirti P Kamdar

William K Wheeler

Methods of obtaining a suspect nodules' sizes and/or growth rate are provided. In one embodiment, the method begins with at a first time: (i) obtaining a first three dimensional (3D) data set cube of voxels of a patient's anatomy including nodules; (ii) creating a second 3D data set cube of the same size as the first where all voxel values are set to zero; (iii) creating multiple Maximum-Intensity-Projection (MIP) images from the first 3D data set cube taken at different angles; (iv) replacing those voxels in the second 3D data set cube with corresponding voxels from the first 3D data set cube that provide non-zero values in the multiple MIP images; and (v) converting data in the second 3D data set cube into closed surface volumes, cross sectional areas or linear dimensions using image segmentation. Data from a second time can be used to determine growth rate.

MIP determination of solid cancer size and size changes based on contrast enhanced MRI and CT imaging

Techniques described herein generally relate to identifying, assessing, and managing cancer growth rates and potential metastasis. Some example methods may include constructing one or more quantitative metrics for the potential metastasis in a selected population of other patients, acquiring a first set of numeric biomarker data for the patient before having placed a biomarker in the patient, acquiring a second set of numeric biomarker data for the patient after having placed the biomarker in the patient, determining a set of biomarker surrogate values for microvessel density information based on a mean numeric biomarker difference derived from the first set of numeric biomarker data and the second set of numeric biomarker data, determining a set of biomarker surrogate values for microvessel density information based on a mean numeric biomarker difference derived from the first set of numeric biomarker data and the second set of numeric biomarker data, and predicting quantitative and objective risk for the cancer growth rates and potential metastasis and adjusting a treatment plan based on the biomarker surrogate values and at least one of the one or more quantitative metrics.

Method and system for identifying, assessing, and managing cancer growth rates and potential metastasis

A photodetector having a semiconductor conversion layer is described. The photodetector is configured to receive x-rays incident on its substrate with the substrate-side contact biased so that the lowest mobility carrier in the semiconductor conversion layer is collected by the substrate side contact.

Photodetector biasing scheme

The present invention provides a device, system and method for uniformly delivering a radiation dose over the surface area of a stenosed vessel during or after a percutaneous transluminal angioplasty procedure. A helical balloon is inflated in the region to be treated, preferably in contact with the vessel wall, and a radiation source is drawn through the helical coils of the balloon to provide a uniform dosage. Alternatively, the helical balloon is disposed within a cylindrical balloon and the helical balloon containing a radiation source with at least one coil is drawn through the cylindrical balloon.

Device and method for delivery of uniform and controlled radiation dose to blood vessels

Growing community of inventors

Mountain View, CA, United States of America

Raisa Pavlyuchkova